Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $26.6 in the prior trading day, Staar Surgical Co (NASDAQ: STAA) closed at $25.38, down -4.59%. In other words, the price has decreased by -$4.59 from its previous closing price. On the day, 0.82 million shares were traded. STAA stock price reached its highest trading level at $26.87 during the session, while it also had its lowest trading level at $25.375.
Ratios:
Our goal is to gain a better understanding of STAA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 5.21. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on April 21, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $17.
Mizuho Downgraded its Outperform to Neutral on February 12, 2025, whereas the target price for the stock was revised from $45 to $17.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when BROADWOOD PARTNERS, L.P. bought 797,486 shares for $27.86 per share. The transaction valued at 22,218,837 led to the insider holds 15,019,491 shares of the business.
BROADWOOD PARTNERS, L.P. bought 393,382 shares of STAA for $10,675,325 on Nov 20 ’25. The 10% Owner now owns 14,222,005 shares after completing the transaction at $27.14 per share. On Nov 19 ’25, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 309,132 shares for $26.42 each. As a result, the insider paid 8,166,155 and bolstered with 13,828,623 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1252907776 and an Enterprise Value of 1108907776. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.47 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 4.809 whereas that against EBITDA is -20.538.
Stock Price History:
The Beta on a monthly basis for STAA is 0.99, which has changed by -0.034246564 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $30.81, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -3.87%, while the 200-Day Moving Average is calculated to be 17.09%.
Shares Statistics:
The stock has traded on average 922.03K shares per day over the past 3-months and 722460 shares per day over the last 10 days, according to various share statistics. A total of 49.35M shares are outstanding, with a floating share count of 49.35M. Insiders hold about 0.79% of the company’s shares, while institutions hold 106.03% stake in the company. Shares short for STAA as of 1763078400 were 3662036 with a Short Ratio of 3.97, compared to 1760486400 on 4012520. Therefore, it implies a Short% of Shares Outstanding of 3662036 and a Short% of Float of 12.94.
Earnings Estimates
The stock of Staar Surgical Co (STAA) is currently in the spotlight, with 5.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.03, with high estimates of $0.13 and low estimates of -$0.21.
Analysts are recommending an EPS of between $0.14 and -$0.06 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.37, with 6.0 analysts recommending between $0.78 and -$0.23.
Revenue Estimates
6 analysts predict $75.55M in revenue for. The current quarter. It ranges from a high estimate of $78.3M to a low estimate of $72.98M. As of. The current estimate, Staar Surgical Co’s year-ago sales were $48.95MFor the next quarter, 6 analysts are estimating revenue of $71.99M. There is a high estimate of $79.1M for the next quarter, whereas the lowest estimate is $60.7M.
A total of 8 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $264.18M, while the lowest revenue estimate was $254.62M, resulting in an average revenue estimate of $258.1M. In the same quarter a year ago, actual revenue was $313.9MBased on 11 analysts’ estimates, the company’s revenue will be $312.29M in the next fiscal year. The high estimate is $344.5M and the low estimate is $271M.
